Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 32171426

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2020 Apr
First author
Swain SM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2020 Apr;21(4):471-472. doi: 10.1016/S1470-2045(20)30058-9.
    note
    Source null
    related pmid
    32171427
    relationship
    Comment in

Authors and identifiers

  1. name
    Swain SM
    type
    Author
  2. name
    Miles D
    type
    Author
  3. name
    Kim SB
    type
    Author
  4. name
    Im YH
    type
    Author
  5. name
    Im SA
    type
    Author
  6. name
    Semiglazov V
    type
    Author
  7. name
    Ciruelos E
    type
    Author
  8. name
    Schneeweiss A
    type
    Author
  9. name
    Loi S
    type
    Author
  10. name
    Monturus E
    type
    Author
  11. name
    Clark E
    type
    Author
  12. name
    Knott A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Swain SM
    type
    Author
  2. name
    Miles D
    type
    Author
  3. name
    Kim SB
    type
    Author
  4. name
    Im YH
    type
    Author
  5. name
    Im SA
    type
    Author
  6. name
    Semiglazov V
    type
    Author
  7. name
    Ciruelos E
    type
    Author
  8. name
    Schneeweiss A
    type
    Author
  9. name
    Loi S
    type
    Author
  10. name
    Monturus E
    type
    Author
  11. name
    Clark E
    type
    Author
  12. name
    Knott A
    type
    Author
bibliography ids
  1. nci-bib-cf28e2fc3874b1fec58d13d5
book metadata
content sha256
e1644eef4f27b41e529d249051c8f31c9cf4230e35244e5f0ca8ea95de6d3464
document type
citation
dois
  1. 10.1016/S1470-2045(19)30863-0
electronic publication date
display
2020 Mar 12
precision
day
year
2020
evidence scope
bibliographic_metadata_only
id
pubmed:32171426
immutable id
pubmed:32171426@e1644eef4f27b41e529d249051c8f31c9cf4230e35244e5f0ca8ea95de6d3464
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
4
name
The Lancet. Oncology
nlm unique id
100957246
pages
519-530
volume
21
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2020 Apr;21(4):471-472. doi: 10.1016/S1470-2045(20)30058-9.
    note
    Source null
    related pmid
    32171427
    relationship
    Comment in
outcomes validated
false
pmid
32171426
provenance
batch id
4c5003fbb78890e89ae1
provider
NCBI PubMed ESummary
record sha256
9bc380e5460064158e050265d7baf58eca754d89440857e94c40ee109d85cf56
response sha256
890389583ce193a9c74e19c63678e418dad2088e82cb704b888b02fcc887d269
retrieved at
2026-09-09T23:47:48.270700+00:00
publication date
display
2020 Apr
precision
month
year
2020
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/32171426/
title
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study.

Preserved source evidence · Not medical advice